UBS Group’s Ensysce Biosciences ENSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $789 | Sell |
354
-954
| -73% | -$2.13K | ﹤0.01% | 8412 |
|
|
2025
Q1 | $3.35K | Buy |
1,308
+713
| +120% | +$1.83K | ﹤0.01% | 7909 |
|
|
2024
Q4 | $4.84K | Sell |
595
-6,917
| -92% | -$56.3K | ﹤0.01% | 7477 |
|
|
2024
Q3 | $27K | Buy |
+7,512
| New | +$27K | ﹤0.01% | 5971 |
|
|
2024
Q2 | – | Sell |
-841
| Closed | -$9.96K | – | 8440 |
|
|
2024
Q1 | $9.96K | Buy |
+841
| New | +$9.96K | ﹤0.01% | 6083 |
|
|
2023
Q4 | – | Sell |
-10
| Closed | -$203 | – | 7959 |
|
|
2023
Q3 | $203 | Buy |
+10
| New | +$203 | ﹤0.01% | 7558 |
|
|
2023
Q2 | – | Sell |
-170
| Closed | -$12.4K | – | 7959 |
|
|
2023
Q1 | $12.4K | Buy |
170
+93
| +121% | +$6.76K | ﹤0.01% | 6359 |
|
|
2022
Q4 | $10.4K | Buy |
77
+63
| +450% | +$8.52K | ﹤0.01% | 7321 |
|
|
2022
Q3 | $11K | Buy |
14
+9
| +180% | +$7.07K | ﹤0.01% | 7182 |
|
|
2022
Q2 | $15K | Buy |
5
+3
| +150% | +$9K | ﹤0.01% | 6244 |
|
|
2022
Q1 | $9K | Sell |
2
-1
| -33% | -$4.5K | ﹤0.01% | 7486 |
|
|
2021
Q4 | $46K | Buy |
+3
| New | +$46K | ﹤0.01% | 5885 |
|